Ardelyx
ARDX
#5098
Rank
โ‚น164.76 B
Marketcap
โ‚น666.99
Share price
-4.00%
Change (1 day)
112.32%
Change (1 year)

P/E ratio for Ardelyx (ARDX)

P/E ratio as of May 2026 (TTM): -28.0

According to Ardelyx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -28.02. At the end of 2024 the company had a P/E ratio of -31.7.

P/E ratio history for Ardelyx from 2014 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-31.7
2022-5.94720.45%
2021-0.7237-88.26%
2020-6.1620.69%
2019-5.11362.06%
2018-1.10-77.23%
2017-4.85
2015-16.3-84.65%
2014-106

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Abbott Laboratories
ABT
23.3-183.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
22.8-181.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
21.0-174.91%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
30.6-209.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
OPKO Health
OPK
-4.69-83.27%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.